Ontogenic changes in CD95 expression on human leukocytes: Prevalence of T-cells expressing activation markers and identification of CD95-CD45RO+ T-cells in the fetus

Developmental and Comparative Immunology

Volumn 27, Issue 10, 2003, Pages 899-914

  Muench, Marcus O ^a   Pott Bärtsch, Eva M ^a   Chen, Jeng Chang ^a   Lopoo, John B ^a   Bárcena, Alicia ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

B cells; Granulocytes; Liver; Monocytes; NK cells; T cells; T cell receptors; Thymus

Indexed keywords

B7 ANTIGEN; CD45 ANTIGEN; CD69 ANTIGEN; FAS ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; FETUS CELL; GRANULOCYTE; HEMATOPOIETIC CELL; HUMAN; HUMAN TISSUE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MONOCYTE; NATURAL KILLER CELL; ONTOGENY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T LYMPHOCYTE; THYMUS;

EID: 0042745689     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-305X(03)00081-8     Document Type: Article

References (53)

1. Renda M.C., Fecarotta E., Dieli F., et al. Evidence of alloreactive T lymphocytes in fetal liver: implications for fetal hematopoietic stem cell transplantation. Bone Marrow Transplant. 25:(2):2000;135-141.
2. Muench M.O., Rae J., Bárcena A., et al. Transplantation of a fetus with paternal Thy-1+CD34+ cells for chronic granulomatous disease. Bone Marrow Transplant. 27:(4):2001;355-364.
3. Furley A.J., Mizutani S., Weilbaecher K., et al. Developmentally regulated rearrangement and expression of genes encoding the T cell receptor-T3 complex. Cell. 46:(1):1986;75-87.
4. Haynes B.F., Martin M.E., Kay H.H., Kurtzberg J. Early events in human T cell ontogeny: phenotypic characterization and immunohistological localization of T-cell precursors in early human fetal tissues. J Exp Med. 168:(3):1988;1061-1080.
5. Haynes B.F. Phenotypic characterization and ontogeny of the human thymic microenviroment. Clin Res. 32:(5):1984;500-507.
6. Stites D.P., Carr M.C., Fudenberg H.H. Ontogeny of cellular immunity in the human fetus: development of responses to phytohemagglutinin and to allogeneic cells. Cell Immunol. 11:(1-3):1974;257-271.
7. Rayfield L.S., Brent L., Rodeck C.H. Development of cell-mediated lympholysis in human foetal blood lymphocytes. Clin Exp Immunol. 42:(3):1980;561-570.
8. Lindton B., Markling L., Ringden O., Kjaeldgaard A., Gustafson O., Westgren M. Mixed lymphocyte culture of human fetal liver cells. Fetal Diagn Ther. 15:(2):2000;71-78.
9. Wang Y.Z., Ning Z.Q., Zhang Q.X. Responses of human fetal splenocytes and thymocytes to interleukin-2 and comparison with adult peripheral blood lymphocytes. Immunol Lett. 37:(2-3):1993;229-233.
10. Garderet L., Dulphy N., Douay C., et al. The umbilical cord blood alphabeta T-cell repertoire: characteristics of a polyclonal and naive but completely formed repertoire. Blood. 91:(1):1998;340-346.
11. Harris D.T., Schumacher M.J., Locascio J., et al. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci USA. 89:(21):1992;10006-10010.
12. Lai R., Visser L., Poppema S. Postnatal changes of CD45 expression in peripheral blood T and B cells. Br J Haematol. 87:(2):1994;251-257.
13. Roncarolo M.G., Bigler M., Ciuti E., Martino S., Tovo P.A. Immune responses by cord blood cells. Blood Cells. 20:(2-3):1994;573-585.
14. Bofill M., Akbar A.N., Salmon M., Robinson M., Burford G., Janossy G. Immature CD45RA(low)RO(low) T cells in the human cord blood. I. Antecedents of CD45RA+ unprimed T cells. J Immunol. 152:(12):1994;5613-5623.
15. Keever C.A., Abu-Hajir M., Graf W., et al. Characterization of the alloreactivity and anti-leukemia reactivity of cord blood mononuclear cells. Bone Marrow Transplant. 15:(3):1995;407-419.
16. Sato K., Nagayama H., Takahashi T.A. Aberrant CD3- and CD28-mediated signaling events in cord blood T cells are associated with dysfunctional regulation of Fas ligand-mediated cytotoxicity. J Immunol. 162:(8):1999;4464-4471.
17. Harris D.T., LoCascio J., Besencon F.J. Analysis of the alloreactive capacity of human umbilical cord blood: implications for graft-versus-host disease. Bone Marrow Transplant. 14:(4):1994;545-553.
18. Risdon G., Gaddy J., Horie M., Broxmeyer H.E. Alloantigen priming induces a state of unresponsiveness in human umbilical cord blood T cells. Proc Natl Acad Sci USA. 92:(6):1995;2413-2417.
19. Porcu P., Gaddy J., Broxmeyer H.E. Alloantigen-induced unresponsiveness in cord blood T lymphocytes is associated with defective activation of Ras. Proc Natl Acad Sci USA. 95:(8):1998;4538-4543.
20. Berthou C., Legros-Maida S., Soulie A., et al. Cord blood T lymphocytes lack constitutive perforin expression in contrast to adult peripheral blood T lymphocytes. Blood. 85:(6):1995;1540-1546.
21. Miyawaki T., Uehara T., Nibu R., et al. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol. 149:(11):1992;3753-3758.
22. Siegel R.M., Chan F.K., Chun H.J., Lenardo M.J. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol. 1:(6):2000;469-474.
23. Krammer P.H. CD95's deadly mission in the immune system. Nature. 407:(6805):2000;789-795.
24. McCloskey T.W., Oyaizu N., Bakshi S., Kowalski R., Kohn N., Pahwa S. CD95 expression and apoptosis during pediatric HIV infection: early upregulation of CD95 expression. Clin Immunol Immunopathol. 87:(1):1998;33-41.
25. Jenkins M., Keir M., McCune J.M. Fas is expressed early in human thymocyte development but does not transmit an apoptotic signal. J Immunol. 163:(3):1999;1195-1204.
26. Potestio M., Pawelec G., Di Lorenzo G., et al. Age-related changes in the expression of CD95 (APO1/FAS) on blood lymphocytes. Exp Gerontol. 34:(5):1999;659-673.
27. Bárcena A., Muench M.O., Song K.S., Ohkubo T., Harrison M.R. Role of CD95/Fas and its ligand in the regulation of the growth of human CD34++CD38- fetal liver cells. Exp Hematol. 27:(9):1999;1428-1439.
28. Bárcena A., Muench M.O., Roncarolo M.G., Spits H. Tracing the expression of CD7 and other antigens during T- and myeloid-cell differentiation in the human fetal liver and thymus. Leuk Lymph. 17:(1-2):1995;1-11.
29. Pilarski L.M., Gillitzer R., Zola H., Shortman K., Scollay R. Definition of the thymic generative lineage by selective expression of high molecular weight isoforms of CD45 (T200). Eur J Immunol. 19:(4):1989;589-597.
30. Egerton M., Pruski E., Pilarski L.M. Cell generation within human thymic subsets defined by selective expression of CD45 (T200) isoforms. Hum Immunol. 27:(4):1990;333-347.
31. Fujii Y., Okumura M., Inada K., Nakahara K., Matsuda H. CD45 isoform expression during T cell development in the thymus. Eur J Immunol. 22:(7):1992;1843-1850.
32. Byrne J.A., Stankovic A.K., Cooper M.D. A novel subpopulation of primed T cells in the human fetus. J Immunol. 152:(6):1994;3098-3106.
33. Testi R., Phillips J.H., Lanier L.L. T cell activation via Leu-23 (CD69). J Immunol. 143:(4):1989;1123-1128.
34. Azuma M., Yssel H., Phillips J.H., Spits H., Lanier L.L. Functional expression of B7/BB1 on activated T lymphocytes. J Exp Med. 177:(3):1993;845-850.
35. Wyss-Coray T., Mauri-Hellweg D., Baumann K., Bettens F., Grunow R., Pichler W.J. The B7 adhesion molecule is expressed on activated human T cells: functional involvement in T-T cell interactions. Eur J Immunol. 23:(9):1993;2175-2180.
36. Lanier L.L., Chang C., Azuma M., Ruitenberg J.J., Hemperly J.J., Phillips J.H. Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56). J Immunol. 146:(12):1991;4421-4426.
37. Devereux G., Seaton A., Barker R.N. In utero priming of allergen-specific helper T cells. Clin Exp Allergy. 31:(11):2001;1686-1695.
38. Alderson M.R., Armitage R.J., Maraskovsky E., et al. Fas transduces activation signals in normal human T lymphocytes. J Exp Med. 178:(6):1993;2231-2235.
39. Kabra N.H., Kang C., Hsing L.C., Zhang J., Winoto A. T cell-specific FADD-deficient mice: FADD is required for early T cell development. Proc Natl Acad Sci USA. 98:(11):2001;6307-6312.
40. Thilaganathan B., Mansur C.A., Morgan G., Nicolaides K.H. Fetal T-lymphocyte subpopulations in normal pregnancies. Fetal Diagn Ther. 7:(2):1992;53-61.
41. Krangel M.S., Yssel H., Brocklehurst C., Spits H. A distinct wave of human T cell receptor gamma/delta lymphocytes in the early fetal thymus: evidence for controlled gene rearrangement and cytokine production. J Exp Med. 172:(3):1990;847-859.
42. Shevach E.M. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol. 2:(6):2002;389-400.
43. Wing K., Ekmark A., Karlsson H., Rudin A., Suri-Payer E. Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood. Immunology. 106:(2):2002;190-199.
44. Webb L.M., Foxwell B.M., Feldmann M. Putative role for interleukin-7 in the maintenance of the recirculating naive CD4+ T-cell pool. Immunology. 98:(3):1999;400-405.
45. Webb L.M., Foxwell B.M., Feldmann M. Interleukin-7 activates human naive CD4+ cells and primes for interleukin-4 production. Eur J Immunol. 27:(3):1997;633-640.
46. Schelonka R.L., Raaphorst F.M., Infante D., Kraig E., Teale J.M., Infante A.J. T cell receptor repertoire diversity and clonal expansion in human neonates. Pediatr Res. 43:(3):1998;396-402.
47. Alfani E., Migliaccio A.R., Sanchez M., Passarelli A.M., Migliaccio G. Characterization of the T cell receptor repertoire of neonatal T cells by RT-PCR and single strand conformation polymorphism analysis. Bone Marrow Transplant. 26:(1):2000;83-89.
48. Medvedev A.E., Johnsen A.C., Haux J., et al. Regulation of Fas and Fas-ligand expression in NK cells by cytokines and the involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicity. Cytokine. 9:(6):1997;394-404.
49. Haux J., Johnsen A.C., Steinkjer B., Egeberg K., Sundan A., Espevik T. The role of interleukin-2 in regulating the sensitivity of natural killer cells for Fas-mediated apoptosis. Cancer Immunol Immunother. 48:(2-3):1999;139-146.
50. De Maria R., Testa U., Luchetti L., et al. Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. Blood. 93:(3):1999;796-803.
51. Cleary A.M., Fortune S.M., Yellin M.J., Chess L., Lederman S. Opposing roles of CD95 (Fas/APO-1) and CD40 in the death and rescue of human low density tonsillar B cells. J Immunol. 155:(7):1995;3329-3337.
52. Bárcena A., Park S.W., Banapour B., Muench M.O., Mechetner E. Expression of Fas/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver. Blood. 88:(6):1996;2013-2025.
53. Josefsen D., Myklebust J.H., Lynch D.H., Stokke T., Blomhoff H.K., Smeland E.B. Fas ligand promotes cell survival of immature human bone marrow CD34+CD38- hematopoietic progenitor cells by suppressing apoptosis. Exp Hematol. 27:(9):1999;1451-1459.